We have also recently described novel amiloride analogues with low nanomolar uPA inhibitory activity, high target selectivity and potent antimetastatic activity in mouse models of human lung and orthotopic pancreatic cancer metastasis [138,139]. This evidence concerns the gene PLAU and pancreatic neoplasm.